Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine.

ABSTRACT: Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5 years after peak outbreak and SARS, MERS, and Zika vaccines are still in clinical development. Despite massive leaps forward in rapid science, other regulatory bottlenecks are hamstringing the global effort for pandemic vaccines.

SUBMITTER: Pregelj L 

PROVIDER: S-EPMC7293492 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature